Ownership history in Man Group plc · 8 quarters on record
This page tracks every 13F SEC filing in which Man Group plc reported a position in ANAPTYSBIO INC (ANAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 12,859 | -50,254 | -79.6% | 0.00% | $394K | $30.62 |
| 2020 Q4 | REDUCED | 63,113 | -47,770 | -43.1% | 0.01% | $1.4M | $21.50 |
| 2020 Q3 | ADDED | 110,883 | +20,044 | +22.1% | 0.01% | $1.6M | $14.75 |
| 2020 Q2 | REDUCED | 90,839 | -15,811 | -14.8% | 0.01% | $2.0M | $22.34 |
| 2020 Q1 | REDUCED | 106,650 | -42,633 | -28.6% | 0.01% | $1.5M | $14.13 |
| 2019 Q4 | ADDED | 149,283 | +145,726 | +4096.9% | 0.01% | $2.4M | $16.25 |
| 2019 Q1 | REDUCED | 3,557 | -1,817 | -33.8% | 0.00% | $260K | $73.05 |
| 2018 Q3 | INITIATED | 5,374 | — | — | 0.00% | $536K | — |
As of 2025 Q4 — sorted by position size